94 studies found for:    Open Studies | "Pleural Diseases"
Show Display Options
Rank Status Study
21 Recruiting Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures
Condition: Lung Biopsy
Interventions: Other: ABPI;   Device: BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug
22 Recruiting Correlation of In-lab Pleural Fluid Glucose Measurements With a Finger Stick Glucometer and Portable Point of Care Testing Device (i-STAT).
Condition: Pleural Effusions
Intervention:
23 Recruiting Pathophysiological Effects of Intrapleural Pressure Changes During Therapeutic Thoracentesis
Conditions: Pleural Effusion;   Exudative Pleuritis
Interventions: Procedure: Therapeutic thoracentesis;   Device: Pleural catheter;   Device: Pleural manometer
24 Not yet recruiting Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic Tool
Condition: Lung Cancer
Intervention: Device: Immunomagnetic Detection
25 Not yet recruiting Comparison of Intrapleural Urokinase and Video-Assisted Thorascopic Surgery in the Treatment of Parapneumonic Pleural Effusion in Children
Condition: Empyema, Pleural
Interventions: Drug: insertion of a chest drain with urokinase instillation;   Procedure: primary video-assisted thorascopic surgery
26 Not yet recruiting Necessity of Using Pleural Drainage Tubes After IMA Harvesting During Cardiac Surgery
Condition: Pleural Effusions Post Coronary Artery Bypass Graft
Intervention: Procedure: No Pleural Chest Tube
27 Recruiting Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions
Condition: Loculated or Non-draining Malignant Pleural Effusions
Intervention: Drug: Combination TISSUE PLASMINOGEN ACTIVATOR (TPA) AND DORNASE ALFA (DNASE)
28 Recruiting Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Conditions: Malignant Pericardial Effusion;   Malignant Pleural Effusion;   Recurrent Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Other: cytology specimen collection procedure;   Procedure: therapeutic procedure;   Drug: targeted therapy;   Other: laboratory biomarker analysis
29 Recruiting Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Brenner Tumor;   Malignant Ascites;   Malignant Pleural Effusion;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Primary Peritoneal Cavity Cancer
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: docetaxel;   Drug: metformin hydrochloride;   Drug: placebo;   Other: laboratory biomarker analysis
30 Recruiting Pigtail Catheter: a Less Invasive Option for Pleural Drainage of Recurrent Hepatic Hydrothorax
Condition: Pleural Effusion
Intervention: Device: Pigtail catheter
31 Recruiting Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing
Conditions: Invasive Aspergillosis;   Pleural Effusion;   Immunosuppression
Intervention:
32 Recruiting Biomarker Levels During Indwelling Pleural cAtheter Sample Testing
Condition: Malignant Pleural Effusions
Intervention:
33 Recruiting Mechanical Ventilation During Cardiac Surgery
Conditions: Respiratory Failure;   Pneumothorax;   Atelectasis;   Aspiration Pneumonia;   Bronchospasm
Interventions: Procedure: Non-ventilation during CPB;   Procedure: Ventilation with CPAP;   Procedure: Ventilation with 5 act/minute;   Device: CPAP;   Device: Ventilator: 5 act/minute
34 Recruiting Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion
Condition: Malignant Pleural Effusion
Interventions: Drug: Bevacizumab;   Drug: Pulvis talci
35 Recruiting Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Malignant Pleural Effusion
Intervention: Drug: Bevacizumab
36 Recruiting Pleural and Pericardial Effusion Following Open Heart Surgery
Conditions: Heart Disease;   Pleural Effusion;   Pericardial Effusion
Intervention: Procedure: pleuracentesis
37 Recruiting Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management
Condition: Pleural Effusion, Malignant
Interventions: Device: Indwelling Pleural Catheter;   Procedure: Talc Pleurodesis
38 Recruiting Tubeless Versus Standard Upper Pole Percutaneous Nephrolithotomy
Conditions: Pleural Effusion;   Pain
Interventions: Device: Double J stent  without nephrostomy;   Device: nephrostomy tube and double J stent
39 Recruiting VATS ( Video-Assisted Thoracoscopy) Compared to Reinsertion of a Thoracostomy Tube for Persistent Haemothorax
Conditions: Haemothorax;   Empyema
Interventions: Procedure: VATS ( Video-Assisted Thoracoscopy );   Procedure: Thoracostomy Tube reinsertion
40 Recruiting Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Bevacizumab;   Drug: recombinant human endostatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years